Liver study tests safety of new drugs in patients with liver disease
NCT ID NCT07546760
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study looks at how the liver handles two experimental drugs, AZD9550 and AZD6234, in people with moderate to severe liver problems compared to healthy volunteers. About 28 adults will receive a single injection of one drug. The goal is to see if liver impairment changes drug levels or safety. No treatment benefit is expected; the focus is purely on safety and drug processing.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AZD9550 and AZD6234 (two experimental drugs given as a single injection under the skin)
What this could lead to
If successful, this study will help determine safe dosing for people with liver problems, potentially making future treatments safer for them.
What could go wrong
This is a very early Phase 1 study with only 28 participants, so results may not apply broadly. The drugs are experimental and their effectiveness is not being tested here.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGChandler, Arizona, 85225, United States
-
Research Site
RECRUITINGRialto, California, 92377, United States
-
Research Site
RECRUITINGMiami Lakes, Florida, 33014, United States
-
Research Site
RECRUITINGSan Antonio, Texas, 78215, United States